Inspiremd (NSPR): Director received 31K units
Michael Berman, Director at Inspiremd, reported a grant / award of 31K units.
- 31K
- Derivative units
- Traded
- Sep 18, 2026
- Filed
- Sep 23, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 17, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On July 17, 2026, InspireMD, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of…”
- Jul 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 23, 2026, InspireMD, Inc. (the “Company”) provided notice to Shane Gleason, the Company’s Chief Commercial Officer, that his position has been eliminated.”
- Aug 17, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- Sep 21, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Nov 12, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Nov 13, 2026Insider · 5 peopleInsiders: 5 purchases (~$455K)
- Nov 16, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Inspiremd
For Inspiremd, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NSPR page.
Other recent filings by Michael Berman, Director
The full history of Michael Berman, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Inspiremd (NSPR) insider traded, and how much?
Michael Berman, Director at Inspiremd, reported a grant / award of 31K units. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Sep 18, 2026. Filed: Sep 23, 2026. That is 5 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Inspiremd recently?
For Inspiremd, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the NSPR page.
Does this mean NSPR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Inspiremd
- SEC Form 4Nov 17, 2026
- SEC Form 4Nov 17, 2026
- SEC Form 4Nov 17, 2026
- SEC Form 4Nov 17, 2026
- SEC Form 4Nov 17, 2026
- SEC Form 4May 29, 2026
Everything OQRO holds on this company is on its NSPR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
